Cardima Completes Six-Month Patient Follow Up Period in REVELATION Tx Clinical Trial; Company Plans to Submit FDA Pre-Market Approval Application in Third Quarter.

Business Wire › June 20, 2002

Linked as:

Extract

Cardima Completes Six-Month Patient Follow Up Period in REVELATION Tx Clinical Trial; Company Plans to Submit FDA Pre-Market Approval Application in Third Quarter.

Business Editors & Health/Medical Writers

FREMONT, Calif.--(BW HealthWire)--June 20, 2002

Cardima(R), Inc. (Nasdaq:CRDM), developer of the REVELATION(TM) Tx and REVELATION(TM) Helix(TM) microcatheter syst...

See the full content of this document

Sponsored links

ver las páginas en versión mobile | web

ver las páginas en versión mobile | web

© Copyright 2012, vLex. All Rights Reserved.

Language

Contents in vLex United States

Explore vLex

For Professionals

For Partners

Company

Other documents:

Computer Industry Almanac: China Leads Cellular Subscriber Ranking; Cellular Subscribers Will Top 2B in 2005. | CORE Announces Laura Bush Visits Chipman Middle School Alameda California for R... | A University of Arkansas for Medical Sciences. | media advisory: new life time fitness johns creek to host vip celebration on may 8, 2008. | Decisión nº OP01-P-2007-005211 de Tribunal de Primera Instancia en lo Penal en Funciones de Control N° 1 de la sección de Responsab... | decisión nº 783 de tribunal primero de protección del niño y adolescente de zu... | Decisión de Tribunal de Protección del Niño y del Adolescente Los Teques de Miranda de March 31 2008 | decisión nº 2c-14055-08 de tribunal segundo de control extensión barlovento de ...